Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
Stock Snapshot
Alkermes(ALKS) stock is priced at $49.17, giving the company a market capitalization of 8.25B. It carries a P/E multiple of 128.65.
As of 2026-08-09, Alkermes(ALKS) stock has fluctuated between $48.71 and $49.90. The current price stands at $49.17, placing the stock +1.0% above today's low and -1.5% off the high.
Alkermes(ALKS) shares are trading with a volume of 959.76K, against a daily average of 2M.
In the last year, Alkermes(ALKS) shares hit a 52-week high of $55.67 and a 52-week low of $25.17.
In the last year, Alkermes(ALKS) shares hit a 52-week high of $55.67 and a 52-week low of $25.17.
ALKS News
Alkermes plc recently reported past second-quarter 2026 results, with revenue rising to US$496.01 million while net income fell sharply to US$0.50 million, and...
New insider activity at Alkermes ( (ALKS) ) has taken place on August 3, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to m...
Analyst ratings
72%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.